Wednesday, March 25, 2026
StLouis.news

Latest news from St. Louis

Story of the Day

Missouri Attorney General orders unlicensed St. Louis-area cannabis retailers to halt sales amid hemp enforcement disputes

AuthorEditorial Team
Published
March 25, 2026/07:09 PM
Section
Justice
Missouri Attorney General orders unlicensed St. Louis-area cannabis retailers to halt sales amid hemp enforcement disputes
Source: Wikimedia Commons / Author: Missouri State Archives

Cease-and-desist letters target retailers operating outside Missouri’s regulated marijuana system

Missouri’s attorney general has ordered more than a dozen St. Louis-area retailers described as unlicensed dispensaries to stop selling cannabis products, escalating a statewide effort to police intoxicating items marketed as “hemp” but sold in ways that resemble regulated marijuana.

The actions center on storefronts such as smoke shops and convenience-oriented retailers that advertise or sell products commonly labeled as THCA flower and other hemp-derived intoxicants. In Missouri’s regulated market, marijuana sales are limited to state-licensed dispensaries overseen by the Department of Health and Senior Services through the Division of Cannabis Regulation. Outside that system, state officials have argued that consumers may be exposed to products without the same testing, packaging, labeling and age-verification requirements imposed on licensed marijuana businesses.

What the state says is at issue

Missouri officials have framed the crackdown as a consumer-protection and public-safety matter, pointing to concerns about products packaged to resemble mainstream candy or snacks and about access by minors. In earlier enforcement announcements, state leaders described a broader strategy that can include cease-and-desist letters, investigations, subpoenas, civil litigation and, where applicable, referrals for criminal prosecution.

State enforcement has also included embargoes and removals of products deemed noncompliant, with regulators describing options ranging from pulling items from shelves to destruction, depending on the circumstances and retailer cooperation.

The legal gray zone: marijuana vs. hemp-derived intoxicants

At the core of the dispute is the fast-growing market for hemp-derived products that can produce intoxicating effects while being sold outside the licensed marijuana framework. Retailers and industry advocates have frequently pointed to federal hemp rules tied to delta-9 THC thresholds, arguing some products qualify as legal hemp even when they resemble marijuana in appearance and use. Licensed cannabis operators and some public officials counter that the marketplace has enabled de facto marijuana sales without the costs and controls required of licensed businesses.

Missouri has attempted to narrow that gap through executive actions, administrative enforcement and partnerships between agencies responsible for cannabis regulation, alcohol and tobacco oversight, and consumer protection.

What happens next for targeted businesses

Cease-and-desist demands typically instruct recipients to stop specific conduct and warn of potential legal consequences if sales continue. Options available to the state can include civil enforcement under consumer-protection laws, actions tied to deceptive marketing or mislabeling claims, and referrals to local prosecutors when alleged conduct implicates criminal statutes.

  • Businesses that comply may remove or discontinue targeted products to avoid litigation.

  • Businesses that contest the demands may seek legal review, argue statutory ambiguity, or challenge the state’s interpretation of hemp-related rules.

  • Licensed marijuana operators continue to press for clearer statewide standards to address competition from unlicensed sellers.

Missouri’s regulated marijuana program requires licensing, product tracking and compliance controls that do not apply uniformly to hemp-derived intoxicants sold outside dispensaries.

The letters to St. Louis-area retailers arrive as Missouri continues to refine enforcement tools and as lawmakers, regulators and industry groups debate whether statewide legislation is needed to define what can be sold, where it can be sold, and under what testing and age-restriction requirements.